Results 121 to 130 of about 1,634 (199)
Molecular Insights into Bromocriptine Binding to GPCRs Within Histamine-Linked Signaling Networks: Network Pharmacology, Pharmacophore Modeling, and Molecular Dynamics Simulation. [PDF]
Int J Mol SciDermawan D +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Pharmaceutical and Biomedical Analysis, 2020
Consulting the national pharmacopoeia, no official quality standard was found for estimation of related substances and assay of atosiban acetate injection, of which main active component is atosiban. To solve this problem, herein, a novel high performance liquid chromatographic (HPLC) method was developed and validated in this study.
Yiqiao Hu, Jinhui Wu
exaly +3 more sources
Consulting the national pharmacopoeia, no official quality standard was found for estimation of related substances and assay of atosiban acetate injection, of which main active component is atosiban. To solve this problem, herein, a novel high performance liquid chromatographic (HPLC) method was developed and validated in this study.
Yiqiao Hu, Jinhui Wu
exaly +3 more sources
International Journal of Biological Macromolecules, 2023
With the advancements of high throughput computational screening procedures, drug repurposing became the privileged framework for drug discovery.
Rahul Sharma +8 more
semanticscholar +1 more source
With the advancements of high throughput computational screening procedures, drug repurposing became the privileged framework for drug discovery.
Rahul Sharma +8 more
semanticscholar +1 more source
Drugs, 2004
Oxytocin antagonists are synthetic analogues that have the nonapeptide structure of oxytocin. They act by competing with oxytocin for receptors in the myometrium. Animal experiments and pilot clinical studies have examined several agents and, of these, atosiban has been the object of extensive clinical trials.
Vassilis, Tsatsaris +2 more
openaire +2 more sources
Oxytocin antagonists are synthetic analogues that have the nonapeptide structure of oxytocin. They act by competing with oxytocin for receptors in the myometrium. Animal experiments and pilot clinical studies have examined several agents and, of these, atosiban has been the object of extensive clinical trials.
Vassilis, Tsatsaris +2 more
openaire +2 more sources
Atosiban for threatened preterm birth: the APOSTEL 8 trial
The LancetRuben Ramirez, Zegarra +2 more
openaire +3 more sources
BJOG: an International Journal of Obstetrics and Gynaecology, 2020 To compare the long‐term effects of tocolysis with nifedipine or atosiban on child outcome at age 2.5–5.5 years.
Christiana N Naaktgeboren +2 more
exaly +2 more sources
Atosiban and nifedipin for the treatment of preterm labor
International Journal of Gynecology and Obstetrics, 2005AbstractObjectiveTo perform a comparison between atosiban (oxytocin antagonist) and nifedipin (calcium channel blocker) for acute treatment of preterm labor and their maternal safety. Methods: A randomized controlled trial study was performed on 80 pregnant women with preterm labor, between 26 and 34 weeks of pregnancy, in Akbar Abadi Teaching Hospital
Maryam Kashanian
exaly +3 more sources
Biochemical Pharmacology, 2022
Clinically, 5-fluorouracil (5-Fu) is a first-line drug for the treatment of patients with colorectal cancer (CRC). However, chemoresistance to 5-Fu-based chemotherapy is a leading obstacle in achieving effective treatment for CRC, especially ...
Mengmeng Wang +13 more
semanticscholar +1 more source
Clinically, 5-fluorouracil (5-Fu) is a first-line drug for the treatment of patients with colorectal cancer (CRC). However, chemoresistance to 5-Fu-based chemotherapy is a leading obstacle in achieving effective treatment for CRC, especially ...
Mengmeng Wang +13 more
semanticscholar +1 more source